-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 MvllIOfEj6k9tEXhTTJT11/CnbYAxIeOntwICBossjvAMTV/p53wnuhQPGywGeCT
 77E5ThOq1J56w2ictf76Lg==

<SEC-DOCUMENT>0001161697-08-000446.txt : 20080428
<SEC-HEADER>0001161697-08-000446.hdr.sgml : 20080428
<ACCEPTANCE-DATETIME>20080428174301
ACCESSION NUMBER:		0001161697-08-000446
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20080101
FILED AS OF DATE:		20080428
DATE AS OF CHANGE:		20080428

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Catalyst Pharmaceutical Partners, Inc.
		CENTRAL INDEX KEY:			0001369568
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		220 MIRACLE MILE
		STREET 2:		SUITE 234
		CITY:			CORAL GABLES
		STATE:			FL
		ZIP:			33134
		BUSINESS PHONE:		(305) 529-2522

	MAIL ADDRESS:	
		STREET 1:		220 MIRACLE MILE
		STREET 2:		SUITE 234
		CITY:			CORAL GABLES
		STATE:			FL
		ZIP:			33134

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Winship M Douglas
		CENTRAL INDEX KEY:			0001378683

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33057
		FILM NUMBER:		08782405

	BUSINESS ADDRESS:	
		BUSINESS PHONE:		305-529-2522

	MAIL ADDRESS:	
		STREET 1:		220 MIRACLE MILE
		STREET 2:		SUITE 234
		CITY:			CORAL GABLES
		STATE:			FL
		ZIP:			33134
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4_ex.xml
<DESCRIPTION>FORM 4 FOR 01-01-2008
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0202</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2008-01-01</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001369568</issuerCik>
        <issuerName>Catalyst Pharmaceutical Partners, Inc.</issuerName>
        <issuerTradingSymbol>CPRX</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001378683</rptOwnerCik>
            <rptOwnerName>Winship M Douglas</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>355 ALHAMBRA CIRCLE</rptOwnerStreet1>
            <rptOwnerStreet2>SUITE 1370</rptOwnerStreet2>
            <rptOwnerCity>CORAL GABLES</rptOwnerCity>
            <rptOwnerState>FL</rptOwnerState>
            <rptOwnerZipCode>33134</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>V.P. of Regulatory Operations</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock, par value $0.001 per share</value>
            </securityTitle>
            <transactionDate>
                <value>2008-01-01</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>1794</value>
                    <footnoteId id="F1"/>
                </transactionShares>
                <transactionPricePerShare>
                    <value>3.01</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>1794</value>
                    <footnoteId id="F2"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">Shares were issued as a bonus in the Reporting Person's capacity as an employee of the Company. Such bonus was set as 3% of
 the Reporting Person's 2007 salary, computed pursuant to the price of the stock at the close of business on November 6,
 2007.</footnote>
        <footnote id="F2">Includes 897 shares of unvested restricted stock, which will vest on July 1, 2008, with respect to which provisions exist to
 allow for the withholding of shares to satisfy tax withholding obligations.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ M. Douglas Winship</signatureName>
        <signatureDate>2008-04-28</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----